Exec Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Chris Searles, co-founder and Chief Executive Officer, and Trevor Smith, co-founder and Chief Technology Officer of DxCheck. The in-person interview was joined by Editor-in-Chief John Jannarone and...

Exec Edge hosted a fireside chat on Dec. 8 at Nasdaq MarketSite with Enzo Villani, Executive Chairman and Chief Investment Officer of AlphaTON Capital Corp. (Nasdaq: ATON). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed how the...

IPO Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Christer Rosen, Chairman and Chief Executive Officer, and Alison Silva, President and Chief Business Officer of Jupiter Neurosciences, Inc. (Nasdaq: JUNS). The in-person interview was joined by...

Exec Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Doyl Burkett, Managing Partner and founder of Integrity Growth Partners (IGP). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the announcement of IGP’s...

By Daniella Parra ReAlta Life Sciences’ Pegtarazimod demonstrated significant clinical improvement and reduction in inflammatory markers in patients with lower gastrointestinal aGvHD, the company said. Clinical MAGIC stage improvement observed for 6 of 6 patients with steroid-refractory aGvHD, with 4...

IPO Edge hosted a fireside chat on Oct. 2 at Nasdaq MarketSite with Andrew Keys, Co-Founder and Chairman of The Ether Machine (Nasdaq: ETHM). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed availing public market investors to...

CorpGov and  IPO Edge are pleased to provide complete video coverage of the fifth annual Palm Beach CorpGov Forum held on Nov. 5-6, featuring a two-day event with panels, firesides and networking receptions. The event comprised an array of speakers...

By Karen Roman March Biosciences said it appointed Gurpreet Ratra, Ph.D., as Chief Business Officer. Dr. Ratra has more than 25 years of experience in the life science industry including cell and gene therapy, as well as equity research leadership, the...

By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) said it is presenting new research at the 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference, being held on December 1-4, 2025, in San Diego, California. Acumen and JCR Pharmaceuticals are...

By Karen Roman ReAlta Life Sciences, Inc. announced the designation of Howard Berman, Ph.D., as Executive Chairman of its Board of Directors, effective immediately. “His proven track record in advancing innovative immunology-based therapies and creating value, positions ReAlta for disciplined growth...